Clinical Trial Update: Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing once versus twice daily bisoprolol for prevention of atrial fibrillation after coronary artery bypass graft surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Grafting
• Postoperative Atrial Fibrillation

Drugs mentioned

• Bisoprolol (Bisoprolol)

Snippet

Sponsor: Cairo University | Conditions: Coronary Artery Bypass Grafting, Postoperative Atrial Fibrillation | Phase 4 | Status: UNKNOWN